A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

NCT06863233 PHASE1 RECRUITING

The purpose of this study to learn whether PET/CT (positron emission tomography/computed tomography) scans using an imaging agent (radiotracer) called zirconium Zr 89 crefmirlimab berdoxam is a safe and effective way to identify CD8+ T cells

Details

Lead sponsor	Memorial Sloan Kettering Cancer Center
Phase	PHASE1
Status	RECRUITING
Enrolment	5
Start date	Mon Mar 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Lung Cancer
• Non Small Cell Lung Cancer
• Metastatic Non Small Cell Lung Cancer

Interventions

• Zirconium Zr 89 crefmirlimab berdoxam
• PET/CT Scan

Countries

United States